Log In
Print this Print this

P/LAIV, Pandemic Live Attenuated Influenza Vaccine

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionIntranasal live attenuated influenza vaccine (LAIV) containing the H5N1 strain of influenza virus
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentRegistration
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza in an officially declared pandemic
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today